Viewing Study NCT04136756

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2026-02-23 @ 9:22 PM
Study NCT ID: NCT04136756
Status: COMPLETED
Last Update Posted: 2023-06-15
First Post: 2019-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma
Sponsor: Nektar Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Non-Hodgkin Lymphoma View
None Indolent Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relapsed View
None refractory View
None NKTR-255 View
None CAR-T View
None daratumumab subcutaneous (sc) View
None interleukin-15 (IL-15) View
None MM View
None NHL View
None indolent View
None rituximab View
None Truxima® View